{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-011827","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2022-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.653085+00:00","generated_at":"2026-06-26T17:13:15.785376+00:00","sec_items":["8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Chief Medical Officer Lance Baldo resigns effective March 25, 2022","bullets":["Lance Baldo resigned as Chief Medical Officer to pursue a new opportunity.","Resignation effective March 25, 2022; no replacement named yet.","Baldo stated no disagreement with the company, management, or board.","Event reported under Item 8.01 as an other-event disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-011827","json":"https://secwatch.observer/filing/0001564590-22-011827.json","markdown":"https://secwatch.observer/filing/0001564590-22-011827.md","text":"https://secwatch.observer/filing/0001564590-22-011827.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000156459022011827/0001564590-22-011827-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000156459022011827/adpt-8k_20220325.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T17:13:15.785376+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}